Opella Healthcare International SAS

Ukraine

All drugs from this manufacturer

  • OBAJIO

    Obajio is indicated for the treatment of adult patients and children aged 10 years and older with relapsing multiple sclerosis.

    Dosage form: tablets, film-coated

    Active substance Dosage
    teriflunomide 7 mg

    ATC: L04AK02

  • The drug is indicated for the treatment of adult patients and children aged 10 years and older with relapsing-remitting multiple sclerosis.

    Dosage form: tablets, film-coated

    Active substance Dosage
    teriflunomide 14 mg

    ATC: L04AK02